Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis.

Jagielski T, Niedźwiecka K, Roeske K, Dyląg M.

Front Pharmacol. 2018 Apr 19;9:375. doi: 10.3389/fphar.2018.00375. eCollection 2018.

2.

Onychomycosis Due to Arthrinium arundinis: A Case Report.

Dyląg M, Hryncewicz-Gwóźdź A, Jagielski T.

Acta Derm Venereol. 2017 Jul 6;97(7):860-861. doi: 10.2340/00015555-2673. No abstract available.

3.

The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate.

Lis P, Dyląg M, Niedźwiecka K, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Molecules. 2016 Dec 15;21(12). pii: E1730. Review.

4.

Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma.

Niedźwiecka K, Dyląg M, Augustyniak D, Majkowska-Skrobek G, Cal-Bąkowska M, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Oncotarget. 2016 Oct 4;7(40):65614-65626. doi: 10.18632/oncotarget.11592.

5.

Dark stains on rock surfaces in Driny Cave (Little Carpathian Mountains, Slovakia).

Ogórek R, Dyląg M, Kozak B.

Extremophiles. 2016 Sep;20(5):641-52. doi: 10.1007/s00792-016-0853-7. Epub 2016 Jun 17.

6.

[Insects as model organisms to study the pathogenesis of fungal infections and evaluation of potential antimycotics].

Niedźwiecka K, Dyląg M.

Med Dosw Mikrobiol. 2015;67(2):133-9. Review. Polish.

PMID:
26591665
7.

Etiological factors of cryptococcosis - what makes them pathogens ?

Dylag M.

Med Dosw Mikrobiol. 2015;67(3-4):221-31. Review.

PMID:
27019916
8.

3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans.

Dyląg M, Lis P, Niedźwiecka K, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Biochem Biophys Res Commun. 2013 May 3;434(2):322-7. doi: 10.1016/j.bbrc.2013.02.125. Epub 2013 Mar 26.

PMID:
23541578
9.

Differential expression of the Candida glabrata CgRTA1 and CgRSB1 genes in response to various stress conditions.

Kołaczkowska A, Dyląg M, Kołaczkowski M.

Biochem Biophys Res Commun. 2013 Mar 1;432(1):169-74. doi: 10.1016/j.bbrc.2013.01.047. Epub 2013 Jan 18.

PMID:
23337499
10.

Molecular typing of Trichophyton rubrum clinical isolates from Poland.

Hryncewicz-Gwóźdź A, Jagielski T, Sadakierska-Chudy A, Dyląg M, Pawlik K, Baran E, Szepietowski JC.

Mycoses. 2011 Nov;54(6):e726-36. doi: 10.1111/j.1439-0507.2010.02007.x. Epub 2011 Sep 14.

PMID:
21917026
11.

A 5-year survey of dermatomycoses in southwest Poland, years 2003-2007.

Jankowska-Konsur A, Dyląg M, Hryncewicz-Gwóźdź A, Plomer-Niezgoda E, Szepietowski JC.

Mycoses. 2011 Mar;54(2):162-7. doi: 10.1111/j.1439-0507.2009.01774.x.

PMID:
19925570
12.

Antifungal activity of organotin compounds with functionalized carboxylates evaluated by the microdilution bioassay in vitro.

Dylag M, Pruchnik H, Pruchnik F, Majkowska-Skrobek G, Ułaszewski S.

Med Mycol. 2010 Mar;48(2):373-83. doi: 10.1080/13693780903188680.

PMID:
19688632
13.

Tinea capitis in southwest Poland.

Jankowska-Konsur A, Dylag M, Szepietowski JC.

Mycoses. 2009 Mar;52(2):193-4. doi: 10.1111/j.1439-0507.2008.01555.x. Epub 2008 Sep 12.

PMID:
18793266

Supplemental Content

Loading ...
Support Center